Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-08

FDA Approved: NIFEDIPINE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved Oceanside Pharmaceuticals' supplemental application for nifedipine (ANDA075289), authorizing a modification to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

SUPPL AP for NIFEDIPINE (NIFEDIPINE)